Author Topic: (Abst.) DMDs for MS and infection risk: A cohort study  (Read 33 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8223
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) DMDs for MS and infection risk: A cohort study
« on: April 01, 2018, 01:43:26 pm »
From PubMed, April 1, 2018--"Disease-modifying drugs for multiple sclerosis and infection risk: A cohort study":


https://www.ncbi.nlm.nih.gov/pubmed/29602795
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
46 Views
Last post April 12, 2016, 08:40:06 pm
by agate
0 Replies
43 Views
Last post August 20, 2016, 09:00:40 am
by agate
0 Replies
37 Views
Last post December 13, 2016, 07:26:06 am
by agate
0 Replies
53 Views
Last post April 23, 2017, 03:47:31 pm
by agate
0 Replies
48 Views
Last post April 27, 2018, 02:07:54 pm
by agate